CLL2-BIG: sequential treatment with bendamustine, ibrutinib and obinutuzumab (GA101) in chronic lymphocytic leukemia
暂无分享，去创建一个
M. Hallek | S. Stilgenbauer | K. Kreuzer | C. Wendtner | T. Illmer | S. Böttcher | M. Ritgen | P. Langerbeins | J. Bahlo | A. Fink | K. Fischer | P. Cramer | Julia von Tresckow | S. Robrecht | O. Al-Sawaf | B. Eichhorst | S. Estenfelder | J. von Tresckow | H. Klaproth